Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
---|
04/05/2007 | US20070078146 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma |
04/05/2007 | US20070078139 Phosphodiesterase 4 inhibitors |
04/05/2007 | US20070078120 Novel piperidine derivative |
04/05/2007 | CA2745829A1 Chemical process |
04/05/2007 | CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases |
04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
04/05/2007 | CA2621255A1 Amido compounds and their use as pharmaceuticals |
04/04/2007 | EP1768959A2 Hetero isonipecotic modulators of vanilloid vr1 receptor |
04/04/2007 | EP1768958A1 New disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission |
04/04/2007 | EP1768954A2 2-methylpropanamides and their use as pharmaceuticals |
04/04/2007 | EP1768658A1 Hydroxyalkylamides |
04/04/2007 | EP1562932B1 4-tetrazolyl-4-phenylpiperidine derivatives for treating pain |
04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
04/04/2007 | EP1383501B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
04/04/2007 | CN1942441A Sulfonyloxy derivatives |
04/04/2007 | CN1939916A Compound for treating AIDS |
04/04/2007 | CN1939907A Production of 1-benzyl-4-piridocarbinol |
04/04/2007 | CN1308443C Preparation of lactams from aliphatic alpha, omega dinitriles |
04/04/2007 | CN1308308C Synthesis of (4-bromopnenyl)(4-piperidyl)methanone-(z)-o-ethyloxime and salts |
04/04/2007 | CN1307875C Compounds, compositions, and methods for controlling biofilms |
04/03/2007 | US7199247 Amide derivative of amlodipine |
04/03/2007 | US7199245 4-imino-n-alkoxy or oxy-polyalkyl-piperidine compounds and their use as polymerization regulators |
04/03/2007 | US7199244 Cyclic amine derivatives and methods of use |
04/03/2007 | US7199243 Antilipemic agents; anticholesterol agents; atherosclerosis; cardiovascular disorders; obesity; antidiabetic agents |
04/03/2007 | US7199239 Chemical compounds |
04/03/2007 | US7199136 Antiinflammatory agents, neutrophil elastase inhibitors; chronic obstructive pulmonary diseases |
04/03/2007 | US7199134 Hydroxamic acid compounds and methods of use thereof |
04/03/2007 | US7199101 N-butyl-2-(N'-(lauroyl or 2-ethylhexanoyl)amino)glutarimide and N-(lauroyl or 2-ethylhexanoyl)-L-glutamic acid dibutylamide; spreadability and high gel strength; cosmetics and antiperspirant stick; hair gels |
04/03/2007 | CA2149044C Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists |
03/29/2007 | WO2007035143A1 Stabilized protease composition |
03/29/2007 | WO2007034325A1 Carboxamide derivatives as muscarinic receptor antagonists |
03/29/2007 | WO2006108965A3 Npy antagonists, preparation and use |
03/29/2007 | US20070073061 Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them |
03/29/2007 | US20070072916 Amino ceramide-like compounds and therapeutic methods of use |
03/29/2007 | US20070072909 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
03/29/2007 | US20070072905 Novel process for preparing dopenzil and its derivatives |
03/29/2007 | US20070072874 Aminoheteroaryl compounds as protein kinase inhibitors |
03/29/2007 | US20070072869 CERTAIN GLYCINE DERIVATIVES AS FACTOR Xa INHIBITORS FOR USE IN THE TREATMENT OF THROMBOTIC DISORDERS |
03/29/2007 | US20070072859 Pharmaceutical compounds |
03/29/2007 | US20070072837 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia |
03/28/2007 | EP1767526A1 Novel arylamidine derivative, salt thereof, and antifungal containing these |
03/28/2007 | EP1765780A1 Piperidine compound and process for preparing the same |
03/28/2007 | EP1765779A1 New substituted piperidines as modulators of dopamine neurotransmission |
03/28/2007 | EP1765778A2 N-sulfonylcarboximidamide apoptosis promoters |
03/28/2007 | EP1765777A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
03/28/2007 | EP1765773A2 Amino, amino acid or peptide conjugates of retinoic acid |
03/28/2007 | EP1765771A2 Formation of tetra-substituted enamides and stereoselective reduction thereof |
03/28/2007 | EP0927163B1 Preparation of 1-butyl-4-piperidinylmethylamine |
03/28/2007 | CN1938291A Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists |
03/28/2007 | CN1938274A Novel piperidines as chemokine modulators (CCR) |
03/28/2007 | CN1938261A Preparation method for aminophenol compound |
03/28/2007 | CN1307157C Novel compounds |
03/28/2007 | CN1307156C Polyarylcarboxamides useful as lipid lowering agents |
03/27/2007 | US7196198 For therapy and prophylaxis of bone diseases, cancer, systemic granuloma, immunological diseases, allergy, atopy, asthma, gumboil, gingivitis, periodontitis, neurocyte death, Alzheimer's diseases, lungs injury, pulmopathy, acute hepatitis |
03/27/2007 | US7196197 Reacting esters of 2,5-bis(2,2,2-trifluoroethoxy)-benzoic acid with primary amino group of 2-(aminomethyl)piperidine; high yield and purity; starting material has low toxicity; arrhythmia |
03/27/2007 | US7196109 Piperidine-1-carboxylic acid (6,7-difluoro-5-phenyl-1H-indazol-3-yl)amide; especially for treating neurodegenerative diseases; kinase inhibitor |
03/27/2007 | US7196103 Indole derivatives as factor Xa inhibitors |
03/27/2007 | US7196102 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
03/27/2007 | US7196100 Opioid receptor antagonists |
03/27/2007 | US7196084 Cdc25 phosphatase inhibitors |
03/27/2007 | US7195751 For the determination of an analyte or analytes such as proteins, peptides, nucleic acids, carbohydrates, lipids, steroids and small molecules by mass analysis |
03/22/2007 | WO2007031865A2 Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
03/22/2007 | WO2006134385A3 Anti-inflammatory agents |
03/22/2007 | WO2006129237A3 Novel piperidine carboxylic acid amide derivatives |
03/22/2007 | WO2006117609A3 Phenoxypropylpiperidines and -pyrrolidines and their use as histamine h3 -receptor ligands |
03/22/2007 | WO2006115353A9 A novel hydroxamic acid derivative as peptide deformylase inhibitor and manufacturing method thereof |
03/22/2007 | WO2006111983A3 NOVEL POLYMORPHIC FORM OF (l-BENZYL-4-[(5,6-DIMETHOXY-l- INDANONE)-2-YL]METHYL PIPERIDINE HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME |
03/22/2007 | WO2006106432A8 4-arylpiperidine derivatives and use thereof for preparing a medicament for the treatment of cns disorders |
03/22/2007 | WO2006105127A3 Hydroxysteroid dehydrogenase inhibitors |
03/22/2007 | US20070066663 disorders of the central and/or peripheral nervous system; minimal interaction with metabolic enzymes, improved selectivity, potentiation, acid resistance, bioavailibility; (3S) N-(2-Methylpropyl)-N-{[2-(trifluoromethyl)-phenyl]methyl}piperidin-3-amine; depression, urinary incontinence; pain |
03/22/2007 | US20070066655 Diarylmethylidene piperidine derivatives and their use as delta opiod receptor agonists |
03/22/2007 | US20070066653 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
03/22/2007 | US20070066652 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
03/22/2007 | US20070066619 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
03/22/2007 | US20070066600 Compounds |
03/22/2007 | US20070066599 New compounds |
03/22/2007 | US20070066598 Compounds |
03/22/2007 | US20070066590 Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism |
03/22/2007 | US20070066586 Aniline derivatives |
03/22/2007 | US20070066581 Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors |
03/22/2007 | CA2622683A1 Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
03/21/2007 | EP1764360A1 Urea derivative |
03/21/2007 | EP1764101A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments |
03/21/2007 | EP1763302A2 Chemical compounds |
03/21/2007 | CN1934104A Compounds for the treatment of diseases |
03/21/2007 | CN1934081A Novel benayl(idene)-lactam derivatives |
03/21/2007 | CN1934079A Anthraquinone compounds as anti cancer compounds |
03/21/2007 | CN1934066A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
03/21/2007 | CN1305849C Method for preparing 3-methylamino piperidine and its salt |
03/20/2007 | US7192983 N-protected/N-substituted-beta-amino hydroxy sulfonates |
03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
03/20/2007 | US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents |
03/20/2007 | US7192969 Ester derivatives |
03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
03/20/2007 | CA2157147C An improved process for the preparation of n-oxyl hindered amine esters |
03/15/2007 | WO2007029078A2 Succinimide and glutarimide derivatives as adrenergic receptor antagonists |
03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
03/15/2007 | WO2007028849A1 Pyrazolecarboxamide derivatives, method of obtaining same and use thereof as inverse antagonists/agonists of the cannabinoid cb1 and opioid mu receptor |